Dirk G. Brockstedt - Jan 5, 2024 Form 4 Insider Report for RAPT Therapeutics, Inc. (RAPT)

Role
CHIEF SCIENTIFIC OFFICER
Signature
/s/ Rodney Young, Attorney-in-Fact
Stock symbol
RAPT
Transactions as of
Jan 5, 2024
Transactions value $
-$20,456
Form type
4
Date filed
1/8/2024, 05:50 PM
Previous filing
Jan 2, 2024
Next filing
Feb 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RAPT Common Stock Sale -$20.5K -898 -3.13% $22.78 27.8K Jan 5, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold solely to pay taxes due upon vesting of the Restricted Stock Units granted on January 30, 2020 for 8,000 shares.
F2 Includes 1,646 shares and two shares acquired by Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on April 28, 2023 and October 31, 2023, respectively.